Global Cardiac Biomarkers Market 2014-20180280035A cardiac biomarker is defined as a measurable substance that is used as an indicator for diagnosis and risk stratification related to CVDs such as ACS, coronary syndromes, MI, and HF. Some of the cardiac biomarkers are CK-MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-Dimer, IMA, MPO, myoglobin, and sCD40L. Cardiac biomarker assays help medical professionals in understanding and differentiating between MI and angina, which assists in the diagnosis and treatment of CVDs. The abnormal concentration of these biomarkers will act as a significant predictor of an adverse cardiovascular condition. Cardiac POC testing offers reliable measurement of cardiac biomarkers and provides results within an hour. Some cardiac POC tests not only save time, but have also been modified to improve the accuracy of the measurement of enzymes and minimize errors. Covered in this Report0280035This report covers the present scenario and the growth prospects of the Global Cardiac Biomarkers market for the period 2014-2018. To calculate the market size, the report considers revenue generated through sales of devices and assays used for cardiac biomarkers to diagnose various CVDs. View our full TOC hereKey Regions
Ortho Clinical Diagnostics Inc.
Other Prominent Vendors
Becton, Dickinson & Co.
diaDexusLifeSignMitsubishi Chemical Europe
Sierra Resources International
Key Market Driver
Increase in Incidence of Cardiac Disorders
For a full, detailed list, view our report.
Key Market Challenge
Lack of Specific Measures to Detect Presence of CVDs
For a full, detailed list,...
Please join StudyMode to read the full document